FDA launches app for health care professionals to report novel uses of existing medicines for patients with difficult-to-treat infectious diseases
FDA launches CURE ID app for health care professionals
Related Articles
Whole genome sequencing-powered ctDNA sequencing for breast cancer detection
Circulating tumour DNA (ctDNA)-based detection of molecular residual disease (MRD) presents a strategy to identify patients at high risk of relapse. In this article, we…
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer | NEJM
Perioperative FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) is a standard therapy for resectable gastric and gastroesophageal junction adenocarcinomas, but recurrence rates remain hig…
Interpreting Changes to Lung Adenocarcinoma Prognosis over Two Decades
Lung cancer is the most common cancer worldwide and the leading cause of cancer-related mortality, accounting for an estimated 1.8 million deaths in 2020.1 Lung…
Mitochondrial Donation and Preimplantation Genetic Testing for mtDNA Disease | NEJM
Children born to women who carry pathogenic variants in mitochondrial DNA (mtDNA) are at risk for a range of clinical syndromes collectively known as mtDNA…
Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models
Vitiello et al. describe how the chemotherapy combination of cisplatin and temozolomide fosters anti-tumor immune surveillance by remodeling the immune microenvironment, inducing hypermutation, and generating…
Estimates and Projections of the Global Economic Cost of 29 Cancers From 2020 to 2050
This decision analytical model study estimates the macroeconomic cost of 29 cancers in 204 countries and territories.
A Real-World Experience in Pan-Tumor Testing for HER2 IHC in More Than 65 000 Solid Tumors
This cohort study examines the use of human epidermal growth factor receptor 2 immunohistochemistry pan-tumor testing among patients with solid tumors.
Bridging tumour classification and treatment
We read with great interest Jennelle C Hodge and colleagues’ Comment on the WHO Classification of Tumours1 and wish to highlight the crucial need to…
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer | NEJM
Perioperative FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) is a standard therapy for resectable gastric and gastroesophageal junction adenocarcinomas, but recurrence rates remain hig…
Vivek Subbiah: How to Foster Long-term Trust in the Biomedical Research Process? – OncoDaily
Vivek Subbiah: How to Foster Long-term Trust in the Biomedical Research Process? / Alex C. Cheng, cancer, NEJM Evidence, OncoDaily, Oncology, Paul A. Harris,